Furthermore, all three doses of CF33-hNIS-anti-PD-L1 virus were able to inhibit growth of the tumor (Figure 11B), indicating a robust anti-tumor potency of this virus against TNBC of human origin. This evidence concerns the gene CD274 and neoplasm.